Tumor necrosis factor alpha promoter polymorphism -308 G/A in Brazilian patients with systemic lupus erythematosus

Human Immunology

Volumn 73, Issue 11, 2012, Pages 1166-1170

  Angelo, Hildson Dornelas ^a,b   da Silva, Helker Albuquerque ^b,c   Asano, Nadja Maria Jorge ^b   Muniz, Maria Tereza Cartaxo ^a   de Mascena Diniz Maia, Maria ^d   de Souza, Paulo Roberto Eleutério ^d  

^a Universidade Estadual de Pernambuco   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^d UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; ALANINE; ETHIDIUM BROMIDE; GLYCINE; NCOL RESTRICTION ENZYME; RESTRICTION ENDONUCLEASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FRACTIONATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ALLELES; BRAZIL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84867846370     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.07.336     Document Type: Article

References (42)

1. Ardoin S.P., Pisetsky D.S. Developments in the scientific understanding of lupus. Arthritis Res Ther 2008, 10:216-218.
2. Sánchez E., Sabio J.M., Callejas J.L., de Ramón E., Garcia-Portales R., García-Hernández F.J., et al. Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus. BMC Med Genet 2006, 7:48.
3. Sestak A.L., Nath S.K., Sawalha A.H., Harley J.B. Current status of lupus genetics. Arthritis Res Ther 2007, 9:210-219.
4. Mina R., Brunner H.I. Pediatric lupus - are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?. Rheum Dis Clin North Am 2010, 36:53-80.
5. Hay E.M., Bacon P.A., Gordon C., Isenberg D.A., Maddison P., Snaith M.L., et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993, 86:447-458.
6. Wouters E.F., Reynaert N.L., Dentener M.A., Vernooy J.H. Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection?. Proc Am Thorac Soc 2009, 6:638-647.
7. Constantini P.K., Wawrzynowicz-Syczewska M., Clare M., Boron-Kaczmarska A., McFarlane I.G., Cramp M.E., et al. Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy. Liver 2002, 22:404-412.
8. López P., Gutiérrez C., Suárez A. IL-10 and TNFα genotypes in SLE. J Biomed Biotechnol 2010, 2010:838390.
9. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
10. Wu W.S., McClain K.L. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). J Interferon Cytokine Res 1997, 17:631-635.
11. Karimi M., Goldie L.C., Cruickshank M.N., Moses E.K., Abraham L.J. A critical assessment of the factors affecting reporter gene assays for promoter SNP function: a reassessment of -308 TNF polymorphism function using a novel integrated reporter system. Eur J Hum Genet 2009, 17:1454-1462.
12. Lee Y.H., Harley J.B., Nath S.K. Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 2006, 14:364-371.
13. Yap D.Y., Lai K.N. Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol 2010, 2010:365083.
14. Price P., Witt C., Allcock R., Sayer D., Garlepp M., Kok C.C., et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999, 167:257-274.
15. Jacob C.O., Fronek Z., Lewis G.D., Koo M., Hansen J.A., McDevitt H.O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990, 87:1233-1237.
16. Abraham L.J., French M.A., Dawkins R.L. Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol 1993, 92:14-18.
17. D'Alfonso S., Colombo G., Della Bella S., Scorza R., Momigliano-Richiardi P. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens 1996, 47:551-555.
18. Tsuchiya N., Kawasaki A., Tsao B.P., Komata T., Grossman J.M., Tokunaga K. Analysis of the association of HLA-DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. Genes Immun 2001, 2:317-322.
19. Sullivan K.E., Wooten C., Schmeckpeper B.J., Goldman D., Petri M.A. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997, 40:2207-2211.
20. Azizah M.R., Kuak S.H., Ainol S.S., Rahim M.N., Normaznah Y., Norella K. Association of the tumor necrosis factor alpha gene polymorphism with susceptibility and clinical-immunological findings of systemic lupus erythematosus. Asian Pac J Allergy Immunol 2004, 22:159-163.
21. Parks C.G., Pandey J.P., Dooley M.A., Treadwell E.L., St Clair E.W., Gilkeson G.S., et al. Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism. Hum Immunol 2004, 65:622-631.
22. Guarnizo-Zuccardi P., Lopez Y., Giraldo M., Garcia N., Rodriguez L., Ramirez L., et al. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 2007, 70:376-382.
23. Jiménez-Morales S., Velázquez-Cruz R., Ramírez-Bello J., Bonilla-González E., Romero-Hidalgo S., Escamilla-Guerrero G., et al. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Hum Immunol 2009, 70:251-256.
24. Studnicka-Benke A., Steiner G., Petera P., Smolen J.S. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996, 35:1067-1074.
25. Sabry A., Sheashaa H., El-Husseini A., Mahmoud K., Eldahshan K.F., George S.K., et al. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine 2006, 35:148-153.
26. Uribe A.G., Vilá L.M., McGwin G., Sanchez M.L., Reveille J.D., Alarcón G.S. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol 2004, 31:1934-1940.
27. Cabrera M., Shaw M.A., Sharples C., Williams H., Castes M., Convit J., et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995, 182:1259-1264.
28. Zúñiga J., Vargas-Alarcón G., Hernández-Pacheco G., Portal-Celhay C., Yamamoto-Furusho J.K., Granados J. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2001, 2:363-366.
29. Tobón G.J., Correa P.A., Gomez L.M., Anaya J.M. Lack of association between TNF-308 polymorphism and the clinical and immunological characteristics of systemic lupus erythematosus and primary Sjögren's syndrome. Clin Exp Rheumatol 2005, 23:339-344.
30. Hirankarn N., Avihingsanon Y., Wongpiyabovorn J. Genetic susceptibility to SLE is associated with TNF-alpha gene polymorphism -863, but not -308 and -238, in Thai population. Int J Immunogenet 2007, 34:425-430.
31. Asghar T., Yoshida S., Kennedy S., Negoro K., Zhuo W., Hamana S., et al. The tumor necrosis factor-alpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum Reprod 2004, 19:2509-2514.
32. Santos M.J., Carmona-Fernandes D., Caetano-Lopes J., Perpétuo I.P., Vidal B., Capela S., et al. TNF promoter -308 G>A and LTA 252 A>G polymorphisms in Portuguese patients with systemic lupus erythematosus. Rheumatol Int 2011, [Online First, 5 May 2011]. 10.1007/s00296-011-1950
33. Lin Y.J., Chen R.H., Wan L., Sheu J.C., Huang C.M., Lin C.W., et al. Association of TNF-alpha gene polymorphisms with systemic lupus erythematosus in Taiwanese patients. Lupus 2009, 18:974-979.
34. van der Linden M.W., van der Slik A.R., Zanelli E., Giphart M.J., Pieterman E., Schreuder G.M., et al. Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus. Genes Immun 2001, 2:373-380.
35. Ma C.Y., Jiao Y.L., Zhang J., Yang Q.R., Zhang Z.F., Shen Y.J., et al. Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatol Int 2010, 32(2):395-412.
36. Jacob C.O. Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch?. Immunol Today 1992, 13:122-125.
37. Jones B.M., Liu T., Wong R.W. Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity. Autoimmunity 1999, 31:117-124.
38. Mageed R.A., Isenberg D.A. Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production. Lupus 2002, 11:850-855.
39. Hajeer A.H., Worthington J., Davies E.J., Hillarby M.C., Poulton K., Ollier W.E. TNF microsatellite a2, b3 and d2 alleles are associated with systemic lupus erythematosus. Tissue Antigens 1997, 49:222-227.
40. Man B.L., Mok C.C. Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus 2005, 14:822-826.
41. Zhou Q.G., Yang X.B., Hou F.F., Zhang X. Successful treatment of massive ascites with intraperitoneal administration of a steroid in a case of systemic lupus erythematosus. Lupus 2009, 18:740-742.
42. Suárez A., López P., Mozo L., Gutiérrez C. Differential effect of IL10 and TNF-α genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 2005, 64:1605-1610.